Skip to main content
logo
Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
3.180
-0.180 (-5.36%)
Oct 14, 2026, 12:56 PM EDT - Market open

Jupiter Neurosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.060.02--0.230.64
Revenue Growth
-----63.44%-43.35%
Gross Profit
-1.82-2.07-0.49-0.95-0.71-0.81
Operating Income
-9.81-8.91-3.09-3.87-3.43-3.91
Net Income
-9.2-8.64-2.44-4.78-4.96-4.2
Earnings Per Share
-18.57-18.75-6.36-13.59-14.61-13.21
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.523.793.770.030.060.33
Total Debt
1.755.320.222.251.90.65
Net Cash (Debt)
-0.23-1.533.55-2.22-1.83-0.32
Net Cash Growth
------
Net Cash Per Share
-0.46-3.319.25-6.31-5.40-1.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.25-5.41-3.91-0.48-1.25-1.74
Free Cash Flow
-7.25-5.41-3.91-0.48-1.25-1.74
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------126.90%
Operating Margin
-15166.68%-40873.19%---1471.38%-612.36%
Pretax Margin
-14220.12%-39662.77%---2125.15%-658.31%
Profit Margin
-14220.12%-39662.77%---2125.15%-658.31%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
68.481611.07----